MDXG News and Press, MiMedx Group Inc

2024-07-02 14:15:08 ET More on MiMedx Group MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on MiMedx Group Historical earnings data for MiMedx Group Financial information for MiMedx Group Read the full...

2024-07-02 07:00:07 ET Ross Osborn from Cantor Fitzgerald issued a price target of $11.00 for MDXG on 2024-07-02 06:15:00. The adjusted price target was set to $11.00. At the time of the announcement, MDXG was trading at $6.7. The overall price target consensus is at $10...

2024-06-26 16:07:23 ET More on MiMedx Group Seeking Alpha’s Quant Rating on MiMedx Group Historical earnings data for MiMedx Group Financial information for MiMedx Group Read the full article on Seeking Alpha For further details see: MiMedx...

MARIETTA, Ga., June 26, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as the Company’s Senior Vice President, Sales si...

2024-06-13 04:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

(NewsDirect) Regenerative medicine is revolutionizing healthcare. It encompasses a range of cutting-edge therapies aimed at repairing or replacing damaged tissues and organs, offering tangible solutions rather than mere symptom management. With a global market projected to surge from USD 29.4...

2024-04-30 21:33:08 ET MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Conference Call April 30, 2024, 04:30 PM ET Company Participants Matt Notarianni - Head of Investor Relations Joe Capper - Chief Executive Officer Doug Rice - Chief Financial Officer Conferen...

2024-04-30 16:05:22 ET More on MiMedx Group MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript MiMedx slips as FDA reaffirms position on Axiofill Seeking Alpha’s Quant Rating on MiMedx Group Historical earnings data for MiMedx Group Fin...

Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management to Host Conference Call Today, April&#...

LPL Financial Holdings Inc. (LPLA) is expected to report $3.77 for Q1 2024 Banco Santander Brasil SA American Depositary Shares each representing one unit (BSBR) is expected to report $0.14 for Q1 2023 EnLink Midstream LLC representing Limited Partner Interests (ENLC) is expected to repor...